Inofolic Combi cps. A30

Inofolic Combi HP is a dietary supplement based on myoinositol and d-hydroxymyoinositol in a 40:1 ratio, folinic acid, and alpha-lactalbumin. It is designed for those with mild weight gain (BMI ≥ 25) and obesity (BMI ≥ 30).

• The description claims that the improved formula with alpha-lactalbumin increases effectiveness by 95%.
• The description claims that the unique combination of inositol in INOFOLIC® Combi HP at a 40:1 ratio positively affects insulin resistance, PCOS symptoms, and fertility.
• The description claims that the softgel capsule form provides better bioavailability of active components compared to powder form, achieving three times the effect of myoinositol and d-hydroxymyoinositol.
• The description claims that the product is suitable for treating polycystic ovary syndrome (PCOS), insulin resistance, prediabetes, and type II diabetes, and is used in controlled ovarian hyperstimulation protocols.